WebJan 15, 2024 · Jan 15 (Reuters) - Medical device maker Thermo Fisher Scientific Inc said on Friday it has completed acquisition of Henogen SA, a Belgium-based viral vector manufacturing business, for about... Web[87 Pages Report] Check for Discount on Global Single-Use Technology for Biopharmaceuticals Market Research Report 2024 report by QYResearch Group. A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted...
Thermo Fisher Completes $875-Million Acquisition of Novasep’s …
WebThermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. WebThermo Fisher Scientific announced the acquisition of Henogen, a Belgian viral vector manufacturing business belonging to Groupe Novasep, for about €725m ($875m) in cash. Thermo Fisher can strengthen contract manufacturing services through the deal. something\u0027s got to give
Thermo Fisher acquires viral vector manufacturing business from Novasep
WebJan 15, 2024 · Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing … WebJan 15, 2024 · WALTHAM, Mass. and LYON, France, Jan. 15, 2024 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe … WebJan 15, 2024 · Medical device maker Thermo Fisher Scientific Inc said on Friday it has completed acquisition of Henogen SA, a Belgium-based viral vector manufacturing … something\u0027s got to give 1962